All In Biotech

Drug Trial Radar · NCT06111183

Evaluation of AUP12602-C as New Topical Treatment for DFUs (DIAMEND STUDY)

Phase-2, Multi-centre, Prospective, Randomized, Standard-of-care Plus Placebo-controlled, Patient and Central Evaluator Blinded, Parallel Arm, Clinical Study to Evaluate Safety, Tolerability and Efficacy of the AUP1602-C as Treatment for Non-healing Neuro-ischemic DFU

Last checked: Nov 19, 2026Latest source record: Feb 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

64

Actual

Start

Jul 21, 2023

Primary completion

Nov 28, 2025

Study completion Nov 28, 2025

Sponsor

Lead sponsor
Aurealis OyIndustry
Sponsor type
Industry
First posted
Nov 1, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 2 study performed in diabetic foot ulcer (DFU) patients with chronic non-healing, neuro-ischemic wounds to investigate the safety, tolerability and efficacy of AUP1602-C.

Conditions

  • Diabetic Foot Ulcer

Interventions

  • AUP1602-CBiological

    AUP1602-C is topically applied on chronic wounds and covered by wound dressing.

  • PlaceboOther

    Placebo is topically applied on chronic wounds and covered by wound dressing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of local and systematic adverse events (AEs)Time frame: 6 weeks
  2. Incidence of Wound ClosureTime frame: 20 weeks

Locations

10 sites in 3 countries. Site status is shown where the registry gives one.

  • Institut für Diabetesforschung Muenster GmbH

    Münster, Germany

  • Hauärztliche und Diabetologische Praxis

    Pirna, Germany

  • Ospedale San Donato

    Arezzo, Italy

  • Azienda Ospedaliero-Universitaria Careggi

    Florence, Italy

  • AOU Pisana - Ospedale S. Chiara

    Pisa, Italy

  • Ospedale S. Jacopo Pistoia, Diabetologia e Diabetic foot unit Aziendale

    Pistoia, Italy

  • Mikomed

    Lodz, Poland

  • Med-Polonia SP. Z O.O.

    Poznan, Poland

  • PODOS Klinika Leczenia Ran Podema sp. z o.o.

    Warsaw, Poland

  • Lecran Centrum Opieki Nad Ranami

    Wroclaw, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.